10 November 2009 – A giant pharmaceutical company is slated to donate 50 million doses of the pandemic H1N1 vaccine to the United Nations public health arm, the World Health Organization (WHO) announced today.
Under a new agreement signed with GlaxoSmithKline, WHO expects to receive the first shipments of the vaccine by the end of November.
WHO has a list of 95 developing countries that are eligible to receive donated vaccines, and aims to secure enough vaccines to cover 10 per cent of the population of these countries.
“We welcome this very generous donation by GlaxoSmithKline, which will go to protect the health of the world’s poorest people,” said WHO Director-General Margaret after signing the agreement at the agency’s Headquarters in Geneva.
Læs videre på: http://www.un.org/apps/news/story.asp?NewsID=32899&Cr=H1N1&Cr1=
